Vera Therapeutics Inc Earnings

Vera Therapeutics Inc’s revenue jumped NaN% since last year same period to $0Mn in the Q2 2025. On a quarterly growth basis, Vera Therapeutics Inc has generated NaN% jump in its revenue since last 3-months.

Vera Therapeutics Inc’s net profit fell -127.04% since last year same period to $-76.53Mn in the Q2 2025. On a quarterly growth basis, Vera Therapeutics Inc has generated -48.05% fall in its net profits since last 3-months.

Vera Therapeutics Inc’s net profit margin jumped NaN% since last year same period to -Inf% in the Q2 2025. On a quarterly growth basis, Vera Therapeutics Inc has generated NaN% jump in its net profit margins since last 3-months.

Vera Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -1.14 - a -39.02% fall from last quarter’s estimates.

Vera Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -1.14.

Vera Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Vera Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.